Study suggests DTC ads may not reach those at highest risk

08/6/2013 | PharmaLive.com

Direct-to-consumer advertising for cholesterol-lowering statin drugs might not be resonating with those who most need treatment, a study published in the Journal of General Internal Medicine found. Researchers found that adults who had seen statin ads were 16% to 20% more likely to get a diagnosis of high cholesterol and 16% to 22% more likely to be treated with a statin than adults who had not seen ads. However, people at high risk for heart trouble who had seen the ads were not more likely to be using statins than their low-risk peers.

View Full Article in:

PharmaLive.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC